Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER(+)HER2(-) breast cancer: a randomized phase 2 trial. (nature.com)

Authors: De Caluwe A … Buisseret L Journal: Nature Medicine Published: 2026-06-25 DOI: https://doi.org/10.1038/s41591-026-04453-z